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Objectives. We determine the prevalence of the metabolic syndrome in an urban population of Zanjan, a province located to the
west of Tehran. Methods. Randomly selected adults >20 years were studied using stratiﬁed sampling. Target study sample was
2941 (1396 males and 1545 females). Metabolic syndrome was diagnosed using Adult Treatment Panel-III (ATP-III) guidelines
when any three of the following were present: central obesity, raised triglycerides ≥150mg/dl, low high-density lipoprotein (HDL)
cholesterol, blood pressure ≥ 130/ ≥ 85mm Hg, and diabetes or fasting plasma glucose (FPG) ≥ 100mg/dl. Results. Metabolic
syndrome was present in 697 (23.7%) subjects (CI 95%:22%–25%, P = .001), prevalence was 23.1% in men and 24.4% in women
(P : .4). The prevalence increased from 7.5% in the population younger than 30y to 45.6% in ages more than 50years. Low HDL
was the most common metabolic abnormality in both sexes. Most of those with metabolic syndrome had three components of
the syndrome (75.6%), 170 subjects (24.4%) had four and none had ﬁve components simultaneously. The prevalence of obesity
(BMI ≥ 30kg/m2), hypercholesterolemia (≥200mg/dl) and high LDL cholesterol (≥130mg/dl) was greater in the metabolic
syndrome group than normal subjects (P = .00). Conclusions. There is a high prevalence of metabolic syndrome in this urban
population of the northern west of Iran. Focus of cardiovascular prevention should be undertaken in this area.
Copyright © 2009 F. Shariﬁ et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
The name of metabolic syndrome has been considered for
the clustering of some cardiovascular risk factors from 1988
[1]. Because of the diﬀerent criteria for the deﬁnition of
the syndrome, the prevalence of the metabolic syndrome
has varied markedly between diﬀerent studies [2, 3]. This
syndrome has become common in the United States [4]a n d
there are some reports about its increasing prevalence in
Asia[5].Althoughsomestudieshavereportedtheprevalence
of individual cardiovascular risk factors among Iranian
population, a few of them reporting from the central parts
of Iran, examined the clustering of multiple risk factors in
adult population [6, 7]. Based on the repots of the ministry
of Health in Iran, Zanjan, is ranking as the fourth province
of Iran for the rate of cardiovascular mortality. The aim of
this study was to investigate the prevalence of the metabolic
syndrome in a representative northern west Iranian urban
population using the ATP-III guidelines.
2.SubjectsandMethods
2.1. Study Population. This study analyzed data from a cross
sectional study (Healthy Heart study), conducted by the
Zanjan University of medical sciences between 2002 and
2003 in Zanjan, the capital of the Iranian province of the
same name. The main ethnic groups living in the province
are Azeries (Turks) and Kurds.
In the original study the anthropometric parameters,
nutritional status and cardiovascular risk factors in the
population of Zanjan was assessed. A stratiﬁed, multistage
random sampling was used and a total of 4000 subjects aged
more than 15 years were enrolled in the study. We excluded
723 subjects for whom some information was missing and
336 people aged less than 20 years. The remaining subjects
were 2941 subjects including 1396 men and 1545 women.
Subjects completed a questionnaire which included dietary
habits,pastmedicalhistory,smoking status,physicalactivity,
and educational levels.2 Experimental Diabetes Research
All the subjects received oral information concerning the
studyandgavetheirwrittenconsent.Thestudywasapproved
by the Ethical Committee of Zanjan University of medical
sciences.
2.2. Measurements. In the original study Waist circumfer-
ences between the lowest rib and the iliac crest at the level
of umbilicus were measured in duplicate to the nearest mm
with ﬂexible tape.
Blood pressure was measured sitting with a random
zero sphygmomanometer. Systolic (Korotkoﬀ phase I) and
diastolic (Korotkoﬀ phase V) blood pressure was measured
twice on the left upper arm and the average used for analysis.
Average systolic blood pressure more than 130mmHg or
diastolic blood pressure more than 85mmHg or current use
ofantihypertensivemedicationswasdeﬁnedashypertension.
Laboratory measurements were done at the laboratory of
Zanjan University of medical sciences, Valie-e-sasr Hospital.
Plasma glucose was measured by the glucose-peroxidase
colorimetric enzymatic method with a sensitivity of 5 mg/dL
and intra-assay coeﬃcients of variation (CV) I.7% in lower
limit and 1.4% in upper limit concentrations. Inter-assay CV
for the assay was 1.1% in lower limit and 0.6% in upper
limit concentrations. Fasting plasma glucose (FPG) more
than 100 mg/dl was deﬁned abnormal in this study.
SerumCholesterolandTriglycerideofalltheparticipants
weremeasuredafter12–14 hoursof fastingwithcolorimetric
method with a sensitivity of 5mg/dl. Intra-assay and inter-
assay CV for the assay was 1.6% and 1.1% in lower
limit and 0.6% and 0.9% for upper limit concentrations
respectively. High-density lipoprotein cholesterol (HDL-C)
was measured after precipitation of the apolipoprotein B-
containing lipoproteins with phosphotungstic acid (Pars
azmoon kit, Iran).
Hypertriglyceridemia was deﬁned as triglyceride (TG)
concentration more than 150mg/dl. HDL Cholesterol less
than 50mg/dL in females and less than 40mg/dL in males
was considered to be abnormal.
In this study, subjects with three or more of the
following ﬁve risk factors of the criteria of the modiﬁed
NCEP III were deﬁned as having metabolic syndrome: (1)
triglycerides ≥150mg/dl, (2) HDL cholesterol < 40mg/dl in
men and <50mg/dl in women, (3) systolic blood pressure
≥130mmHg or diastolic blood pressure ≥85mmHg, (4)
fasting plasma glucose ≥100mg/dL and (5) Truncal obesity
(waist circumference more than 102cm in men and >88cm
in women). Subjects with a history of hyperlipidemia,
hypertension, or diabetes were considered to have the risk
factor, regardless of the biochemical or clinical values.
2.3. Statistical Analyses. The data are presented as fre-
quencies, percentages, and 95% conﬁdence intervals. The
prevalence of diﬀerent abnormalities was compared using x2
test. Logistic regression analysis was used to detect the value
ofvariablessuchasbodymassindex(BMI)andhypercholes-
terolemia to predict the existence of metabolic syndrome.
The analysis was done with SPSS 11.5 software package. P
value of <. 05 was considered statistically signiﬁcant.
3. Results
The prevalence of the metabolic syndrome in the study
population was 23.7% (CI 95%:22% to 25%, P: .001). The
prevalence of metabolic syndrome was the same in women
and men (24.4%, CI 95%: 22%–26% versus 23.1 %, CI
95%: 21%–25%, resp.) (P = .4). There was a signiﬁcant age-
related increase in the prevalence of metabolic syndrome
in both of the genders. Prevalence of metabolic syndrome
increased from 7.5% within the 20–29-year-old group to
44.7% in people more than 60 years of age. The prevalence
of individual components of the metabolic syndrome is
reported in Table 1. In men and women, respectively, central
obesity was in 148 (10.6%) and 635 (41.4%), hypertension
in 316 (22.6%) and 306 (19.8%), low HDL cholesterol in 880
(63%)and1441(93.3%),hightriglyceridesin600(43%)and
587 (38.4%), and impaired fasting glucose or diabetes in 252
(18.1%)and296(19.2%).Prevalenceofotheratherosclerosis
risk factors in men and women, respectively, was diabetes
in 65 (4.7%) and 88 (5.7%) and high total cholesterol
≥200mg/dl in 428 (30.7%) and 613 (39.7%). Overweight
(BMI: 25–29.9kg/m2) was detected in 1068 (36.3%) and
obesity (BMI => 30kg/m2) was observed in 437 subjects
(14.8%).
Low HDL-C was the most common metabolic abnor-
mality in both sexes. Mean serum HDL-C was 36.9 ±
5.3mg/dl in those with the metabolic syndrome and 46.7 ±
6mg/dl in normal individuals without any risk factors (P<
.001). Except for hypertension and hypertriglyceridemia, all
abnormalities were more common in women than in men
(P : .00). Most of those with metabolic syndrome had
three components of the syndrome (75.6%), 170 subjects
(24.4%) had four components. None of the people had ﬁve
components.
Table 2 shows the mean value of coronary risk factors
in subjects with metabolic syndrome as compared to those
without. BMI ≥ 30kg/m2 as well as high total and LDL
cholesterol, which are not part of the metabolic syndrome,
are also more prevalent among men and women with
this condition. Elevated LDL-C more than 130mg/dl was
found in 13.5% of normal men versus 44.1% of those with
metabolic syndrome (P : .00). In females high LDL-C was
detected in 19.6% versus 58% in normal subjects and those
with metabolic syndrome respectively (P : .00).
Within the 20–29-year-old group of the general popu-
lation, 13.4% had no abnormality (23% of males and 5.6%
of females), while this ﬁgure dropped to 3.4% in people
above 60 years of age (5.8% of males and 0.9% of females).
Totally 13.3% of males and only 3.4% of females had no
cardiovascular risk factor in the population.
4. Discussion
The results of this study indicate that according to ATP III
criteria, 23.7% of the studied adult population has metabolic
syndrome. Since the study population is representative, the
ﬁndings can be generalized to the whole urban population of
the northern west of Iran.Experimental Diabetes Research 3
Table 1: Prevalence of individual abnormalities of the metabolic syndrome by age in urban population of Zanjan, Iran. Numbers in
parentheses are percent. FPG; fasting plasma glucose, TG; triglyceride, HDL; high density lipoprotein, WC; weist circumference High TG:
TG > 150mg/dl, Low HDL: HDL < 50 in female and <40mg/dl in male, High WC: WC ≥ 88cm in female and ≥102cm in male, High BP:
BP ≥ 130/85mmHg.
Age groups (years) FPG ≥ 100mg/dl High TG Low HDL High WC High BP
Men (n : 1396)
20–29 41 (9.9) 127 (30.4) 232 (55.5) 12 (2.9) 34 (8.1)
30–39 49 (14.8) 171 (52.3) 217 (65.6) 23 (6.9) 57 (17.2)
40–49 46 (17.1) 129 (47.8) 146 (65.2) 44 (16.3) 64 (23.7)
50–59 44 (29.3) 89 (58.6) 105 (69.1) 29 (19.1) 60 (39.5)
+60 72 (32.1) 83 (36.9) 150 (66.7) 114 (54) 101 (44.9)
Total 252 (18.1) 599 (43) 880 (63) 154 (9.7) 316 (22.6)
Women (n : 1545)
20–29 33 (6.4) 119 (23) 482 (93) 79 (15.3) 22 (4.2)
30–39 60 (16.2) 124 (33.5) 346 (93.3) 142 (38.3) 33 (8.9)
40–49 59 (21.6) 133 (48.7) 258 (94.2) 159 (58) 59 (21.5)
50–59 60 (35.1) 102 (59.6) 157 (91.8) 114 (66.7) 76 (44.4)
+60 84 (40.2) 113 (54.1) 198 (93.8) 141 (66.8) 116 (55)
Total 296 (19.2) 591 (38.4) 1441 (93.3) 645 (38.3) 306 (19.8)
Table 2: Comparison between subjects with metabolic syndrome and normal people for the mean value of atherosclerosis risk factors. BMI,
body mass index; WC, Waist circumference; BP, Blood pressure; LDL, low density lipoprotein; HDL, high density lipoprotein.
Variables Men (n : 1396) Women (n : 1545)
Normal
∗ (n : 185) Metabolic syndrome (n : 321) P value Normal (n : 52) Metabolic syndrome (n : 376) P value
BMI (kg/m2) 22.5 ± 3.8 26.4 ± 4.2 0.00 23 ± 4.2 28.5 ± 4.4 0.00
WC (Cm) 80.5 ± 10.7 94.2 ± 11 0.00 76.8 ± 9.8 93.2 ± 10.7 0.00
BP (mmHg) 0.00 0.00
Systolic 112 ± 9.4 140 ± 21.9 108.5 ± 9.8 139.7 ± 23
Diastolic 73.2 ± 8.1 86.2 ± 12 72.3 ± 8.4 87 ± 12.7
LDL-C (mg/dl) 99.3 ± 30.5 123.6 ± 37.7 0.00 105.4 ± 32 137 ± 42 0.00
Cholesterol (mg/dl) 162 ± 30 203 ± 40 0.00 175.3 ± 33.6 218 ± 50 0.00
HDL-C (mg/dl) 44.5 ± 4.4 34.5 ± 4.4 0.00 54.2 ± 5.9 37.1 ± 5.6 0.00
Triglyceride (mg/dl) 91 ± 29.7 260 ± 141 0.00 82 ± 31 247 ± 136 0.00
∗Normal people are those without any components of metabolic syndrome.
The prevalence of MS varies considerably worldwide.
Some of the diﬀerences in the prevalence of MS might
arise from varied deﬁnitions of the syndrome. For instance,
Trevisan et al. [8] reported a prevalence of 3–3.5% in Italy on
the basis of the presence of all ﬁve criteria. However, a wide
variation in the prevalence can be observed even with using
the same diagnostic criteria. For example, the frequency of
MS in a sample of the Chinese population was recorded as
9.8% for men and 17.8% for women [9]. In a rural area
of South Korea, MS was found to aﬀect 29.4% of the adult
population above 40 years of age [10], and similar values
were established in Mexico, where 26.6% of the population
studied exhibited the syndrome [11].
Although the prevalence of the metabolic syndrome in
this study is higher than some previously reported from the
USA, Italy, and Finland [4, 8, 10, 12], it is close to that
reportedfromBrazil[13],Indianurbanpopulation[14],and
some reports from the US [15, 16]. High prevalence of MS
also has been reported from Tehran (33%) and Isfahan, two
main capital cities in the central part of Iran (24.2%) [6, 7].
The exact reasons for high prevalence of MS in our study
remain to be determined, but it is evident that substantial
socioeconomic changes have occurred in the population
over the past decades and the transition from a traditional
to a western-like urban lifestyle has been associated with
adverse changes in lifestyle habits. Based on the results
of a national proﬁle of non-communicable disease risk
factors in Iran, 2005 [17] ﬁber intake is low in zanjan
population (ninety four percent have less than three units
per week of vegetables and fruits) and most of them use
high saturated fat (67%) for daily cooking. Only 10% of
the population has regular walking at least three times per4 Experimental Diabetes Research
week.Physicalinactivityhasbeenreportedin58.8%ofmales
and 76.3% of females in Iran [17]. Based on international
questionnaire for physical activity only 11% of Zanjan
population have sever physical activity at least one time
per week and 30% have moderate physical activity at least
three times per week. Although high-fat, high-carbohydrate
diet; and the sedentary lifestyle have been reported for
Iranian population [18], the role of genetic factors should
not be omitted. Although in Iran, women generally have
less physical activity, and overweight and obesity are more
common among them [19], we did not ﬁnd a signiﬁcant
diﬀerence between men and women for the prevalence of
MS. Ford and coworkers [4] also observed little overall
diﬀerence between men and women (24% versus 23.4%,
resp.); however, among African-Americans and Mexican-
Americansthedisorderwasmorecommoninwomen.Inthis
study, the greatest diﬀerence observed between the two sexes
wastheprevalenceofabdominalobesity(9.7%inmenversus
38.3% in women).
In our study the single most common abnormality
was low HDL-C (overall 73%), which is more than what
had previously been reported from USA [20], Turkey [21],
Italy [22], Canada [23], and UK [24]. A high prevalence
of low HDL-C has been reported previously in Iranian
population [25, 26] and is very close to that was reported
from Turkish [27]. This could not only be attributed to
environmental factors but may also be due to genetic
predispositions. Previous family and twin studies [28–30]
have suggested that genetic polymorphism accounts for 40–
60% of the interindividual variation in plasma HDL-C level.
Surprisingly, low HDL-C was more prevalent in females in
our study. Most of the women had HDL-C concentrations
between 45 and 50mg/dl and with lowering the cutoﬀ points
to 40mg/dl the prevalence drops signiﬁcantly in females
(53% for women versus 63% for men).
Apositi v ee ﬀectofageontheprevalenceof thesyndrome
in both sexes was detected in this study and resulted in
45.5% of MS in subjects more than 50 years. This eﬀect has
been reported in other studies [4]. Age-related increases in
insulin resistance have been shown in young, middle-aged,
and elderly healthy normal-weight adults [31], and an age-
related diﬀerence in the degree of clustering of risk variables
[32]h a sb e e nr e p o r t e dt o o .
In conclusion the present study from the northern west
of Iran demonstrated that MS is a serious problem among
the urban populations of this country aﬀecting primarily
older individuals. Since the Iranian population, composed
mainly of those less than 30 years old, it is very likely
that the prevalence of MS will be even greater in the next
decades. The prevention and treatment of this condition
is of major public concern and urgently requires the
application of appropriate policies and considerable invest-
ment.
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